- Current languageen
Pharmaceuticals - Community Register
List of nationally authorised veterinary medicinal products
For treatment of congestive heart failure (according to New York Heart Association (NYHA) classification grade II, III & IV) caused by valvular insufficiency due to chronic degenerative valvular heart disease (endocardiosis) or cardiomyopathy, with or without adjunct therapy with the diuretic furosemide and / or the cardiac glycosides digoxin or methyldigoxin.
For the reduction of elevated systolic blood pressure (between 160 and 230 mm Hg) and the control of associated clinical signs.
|Marketing Authorisation Holder:||Not applicable|
|Close date procedure||Procedure type||EMEA number||Decision||summary publ||decision docs||annex|
|28/04/2010||Referral||EMEA/V/A-39/51||(2010)2845 of 27/04/2010|